UBS Group’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-80,100
Closed -$35.2K 9858
2022
Q4
$35.2K Buy
80,100
+75,573
+1,669% +$33.3K ﹤0.01% 5917
2022
Q3
$1K Sell
4,527
-51,002
-92% -$11.3K ﹤0.01% 9093
2022
Q2
$20K Buy
+55,529
New +$20K ﹤0.01% 5874
2022
Q1
Sell
-20,613
Closed -$26K 9979
2021
Q4
$26K Buy
+20,613
New +$26K ﹤0.01% 6452
2021
Q2
Sell
-41,500
Closed -$108K 8795
2021
Q1
$108K Buy
41,500
+32,099
+341% +$83.5K ﹤0.01% 4923
2020
Q4
$26K Buy
9,401
+5,245
+126% +$14.5K ﹤0.01% 5756
2020
Q3
$19K Buy
4,156
+2,822
+212% +$12.9K ﹤0.01% 5497
2020
Q2
$4K Buy
+1,334
New +$4K ﹤0.01% 6635
2020
Q1
Sell
-4,469
Closed -$23K 7346
2019
Q4
$23K Sell
4,469
-32,048
-88% -$165K ﹤0.01% 5737
2019
Q3
$236K Buy
36,517
+7,373
+25% +$47.7K ﹤0.01% 4235
2019
Q2
$182K Buy
29,144
+28,434
+4,005% +$178K ﹤0.01% 4158
2019
Q1
$8K Buy
+710
New +$8K ﹤0.01% 6130
2018
Q4
Sell
-942
Closed -$19K 7303
2018
Q3
$19K Buy
942
+639
+211% +$12.9K ﹤0.01% 5917
2018
Q2
$6K Sell
303
-3,325
-92% -$65.8K ﹤0.01% 6502
2018
Q1
$39K Sell
3,628
-2,399
-40% -$25.8K ﹤0.01% 5046
2017
Q4
$254K Buy
6,027
+2,617
+77% +$110K ﹤0.01% 3870
2017
Q3
$187K Buy
3,410
+2,560
+301% +$140K ﹤0.01% 4045
2017
Q2
$158K Buy
850
+553
+186% +$103K ﹤0.01% 4026
2017
Q1
$35K Sell
297
-539
-64% -$63.5K ﹤0.01% 4859
2016
Q4
$83K Buy
836
+663
+383% +$65.8K ﹤0.01% 4534
2016
Q3
$19K Sell
173
-8
-4% -$879 ﹤0.01% 5447
2016
Q2
$18K Hold
181
﹤0.01% 5511
2016
Q1
$17K Sell
181
-366
-67% -$34.4K ﹤0.01% 5493
2015
Q4
$79K Buy
547
+502
+1,116% +$72.5K ﹤0.01% 4398
2015
Q3
$5K Buy
+45
New +$5K ﹤0.01% 6308